CRSPCRISPR Therapeutics AG
$49.39-28% 1Y
$49.39
$44.3452 weeks$73.97
Is the business good?
Watch
1 to watch, 3 without dataMargins compressing. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margin direction, 3 years−8001.8 ptsderived
Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
Biotechnology
The closest names by size in the same industry